CLINICAL_TRIALS
trial_result
· 2017-09-20
Clinical Trial Update: Topical Composition Therapy (2013-MCN-333) for the Treatment of Melasma [Phase 2]
Summary
Phase 2 clinical trial update for a topical composition therapy in treating melasma; the study completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Melasma | Phase 2 | Status: COMPLETED | Results posted: 2017-09-20